A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

Launched by ROSWELL PARK CANCER INSTITUTE · Feb 12, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new support program designed to help Black women who have survived breast cancer transition back to everyday life after treatment. The program is focused on Black women in Western New York, an area where many face challenges related to both cancer and poverty. It includes group support sessions where participants can connect with others, learn about health and wellness, and take part in activities like cooking lessons and guest talks. Additionally, each participant will have a one-on-one mentoring session with a long-term breast cancer survivor who will guide them in self-assessments and help them make plans to improve their health.

To be eligible for this program, participants should be at least 18 years old, identify as Black or African American, live in Western New York, and have completed their primary breast cancer treatment (like chemotherapy or surgery, but not including breast reconstruction). The program aims to provide valuable resources and support to help these women navigate their new lives after treatment, so they feel empowered and connected to their community. If you or someone you know fits these criteria, this trial could be a wonderful opportunity for support and growth.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Self-identify as Black or African American but may include other breast cancer survivors
• • Ability to speak and read English
• • At least 18 years of age or older
• • Live in the Western New York area
• • Has been diagnosed with breast cancer (any stage)
• • Has completed primary breast cancer treatments (i.e., systemic, radiation, and/or surgical interventions other that breast reconstruction surgeries)
• • Mentors are at least one-year post-treatment completion
• • Mentees are less than one-year post-treatment completion
• • Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these therapies do not meet exclusion criteria)
• Exclusion Criteria:
• • Currently receiving neoadjuvant and/or adjuvant systemic and/or radiations therapies
• • Unwilling or unable to complete the assessment in English
• • Are pregnant or nursing
• • Are unwilling or unable to follow protocol requirements
• • Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these therapies do not meet exclusion criteria)